Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study von Salles, Gilles, Duell, Johannes, González Barca, Eva, Tournilhac, Olivier, Jurczak, Wojciech, Liberati, Anna Marina, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, André, Marc, Kalakonda, Nagesh, Dreyling, Martin, Weirather, Johannes, Dirnberger-Hertweck, Maren, Ambarkhane, Sumeet, Fingerle-Rowson, Günter, Maddocks, Kami

Volltext

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma von Duell, Johannes, Maddocks, Kami J., González-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, De Vos, Sven, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Abrisqueta, Pau, Kalakonda, Nagesh, André, Marc, Dreyling, Martin, Menne, Tobias, Tournilhac, Olivier, Augustin, Marinela, Rosenwald, Andreas, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Salles, Gilles

Volltext

Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma von Duell, Johannes, Maddocks, Kami J., González-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, De Vos, Sven, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Abrisqueta, Pau, Kalakonda, Nagesh, André, Marc, Dreyling, Martin, Menne, Tobias, Tournilhac, Olivier, Augustin, Marinela, Rosenwald, Andreas, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Salles, Gilles

Volltext

Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T‐cell therapy can be identified before cell a... von Sýkorová, Alice, Folber, František, Polgárová, Kamila, Móciková, Heidi, Ďuraš, Juraj, Steinerová, Kateřina, Obr, Aleš, Heindorfer, Adriana, Ladická, Miriam, Lukáčová, Ľubica, Čellárová, Erika, Plameňová, Ivana, Belada, David, Janíková, Andrea, Trněný, Marek, Jančárková, Tereza, Procházka, Vít, Vranovský, Andrej, Králiková, Margaréta, Vydra, Jan, Smolej, Lukáš, Drgoňa, Ľuboš, Sedmina, Martin, Čermáková, Eva, Pytlík, Robert

Volltext

TP53 Mutation and Complex Karyotype Portends a Dismal Prognosis in Patients With Mantle Cell Lymphoma von Obr, Aleš, Procházka, Vít, Jirkuvová, Andrea, Urbánková, Helena, Kriegova, Eva, Schneiderová, Petra, Vatolíková, Michaela, Papajík, Tomáš

Volltext

Ibrutinib in Mantle Cell Lymphoma Patients: Analysis of the Czech Lymphoma Study Group von Obr, Aleš, Klener, Pavel, Janíková, Andrea, Mocikova, Heidi, Belada, David, Šálek, David, Sýkorová, Alice, Jirkuvová, Andrea, Papajík, Tomáš, Trněný, Marek

Volltext

COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic von Čerňan, Martin, Szotkowski, Tomáš, Obr, Aleš, Látal, Vojtěch, Hluší, Antonín, Krhovská, Petra, Klementová, Olga, Kolář, Milan, Sauer, Pavel, Faber, Edgar, Fürst, Tomáš, Papajík, Tomáš

Volltext

Current perspective on diagnosis and treatment of primary central nervous system lymphomas von Jirkuvová, Andrea, Procházka, Vít, Obr, Aleš

Volltext

Long-term analyses from L-MIND, a phase II study of tafasitamab (MOR208) combined with lenalidomide (LEN) in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R... von Düll, Johannes, Maddocks, Kami J., Gonzalez-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, Obr, Aleš, Gaidano, Gianluca, Abrisqueta, Pau, André, Marc, Dreyling, Martin H., Menne, Tobias, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet Vijay, Salles, Gilles A.

Volltext

High TP53 Mutation Load Predicts Primary Refractory Mantle Cell Lymphoma von Obr, Aleš, Klener, Pavel, Kriegova, Eva, Zemanova, Zuzana, Urbankova, Helena, Jirkuvova, Andrea, Petrackova, Anna, Cudova, Barbora, Sedlarikova, Lenka, Prochazka, VIT K, Papajik, Tomas, Trneny, Marek

Volltext

Long-Term Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma von Maddocks, Kami J., Duell, Johannes, González-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, de Vos, Sven, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Abrisqueta, Pau, André, Marc, Dreyling, Martin, Menne, Tobias F, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Salles, Gilles

Volltext

Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma von Duell, Johannes, Maddocks, Kami J., González-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, de Vos, Sven, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Abrisqueta, Pau, André, Marc, Dreyling, Martin, Menne, Tobias F, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Salles, Gilles A.

Volltext

Update of the single-arm phase II L-MIND study of MOR208 + lenalidomide (LEN) in relapsed/refractory diffuse large B-cell lymphoma (R-R DLBCL): Response rates in patient subgroups... von Maddocks, Kami J., Duell, Johannes, González Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, André, Marc, Kalakonda, Nagesh, Dreyling, Martin H., Zinzani, Pier Luigi, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet Vijay, Salles, Gilles A.

Volltext

Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma von Duell, Johannes, Maddocks, Kami J, González Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, Vos, Sven de, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Abrisqueta Costa, Pau, Kalakonda, Nagesh, André, Marc, Dreyling, Martin, Menne, Tobias, Tournilhac, Olivier, Augustin, Marinela, Rosenwald, Andreas, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Salles, Gilles

Volltext

Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind von Salles, Gilles Andre, Duell, Johannes, González-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Andre, Marc, Kalakonda, Nagesh, Dreyling, Martin, Zinzani, Pier Luigi, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Maddocks, Kami J.

Volltext

Rituximab Maintenance Failure in Mantle Cell Lymphoma Is Associated with High Risk of Death: Analysis of the Czech Lymphoma Study Group (CLSG) von Obr, Aleš, Prochazka, Vit, Papajik, Tomas, Klener, Pavel, Janikova, Andrea, Salek, David, Belada, David, Pytlik, Robert, Sýkorová, Alice, Mocikova, Heidi, Simkovic, Martin, Campr, Vit, Dlouha, Jitka, Fuerst, Tomas, Trněný, Marek

Volltext

LYMRIT 37-01: A Phase I/II Study of 177lu-Lilotomab Satetraxetan (Betalutin®) Antibody-Radionuclide-Conjugate (ARC) for the Treatment of Relapsed Non-Hodgkin's Lymphoma (NHL) — Ana... von Kolstad, Arne, Madsbu, Ulf, Beasley, Matthew, Bayne, Michael, Illidge, Tim M., O'Rourke, Noelle, Lagerlöf, Ingemar, Hajek, Roman, Jurczak, Wojciech, Willenbacher, Ella, Fagerli, Unn Merete, Obr, Aleš, Blakkisrud, Johan, Muftuler Løndalen, Ayca, Rojkjaer, Lisa, Østengen, Åse, Bolstad, Nils, Spetalen, Signe, Erlanson, Martin, Galleberg, Renate, Nygaard Rudå, Stine, Holte, Harald

Volltext

ABCL-170: Long-Term Outcomes from the Phase II L-MIND Study of Tafasitamab (MOR208) Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma von Salles, Gilles, Duell, Johannes, González-Barca, Eva, Jurczak, Wojciech, Marina Liberati, Anna, de Vos, Sven, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Abrisqueta, Pau, Kalakonda, Nagesh, André, Marc, Dreyling, Martin, Menne, Tobias, Tournilhac, Olivier, Augustin, Marinela, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Maddocks, Kami J

Volltext

Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma von Kolstad, Arne, Illidge, Tim, Bolstad, Nils, Spetalen, Signe, Madsbu, Ulf, Stokke, Caroline, Blakkisrud, Johan, Løndalen, Ayca, O'Rourke, Noelle, Beasley, Matthew, Jurczak, Wojciech, Fagerli, Unn-Merete, Kaščák, Michal, Bayne, Mike, Obr, Aleš, Dahle, Jostein, Rojkjaer, Lisa, Pascal, Veronique, Holte, Harald

Volltext

Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma in the real world von Vodicka, Prokop, Benesova, Katerina, Janikova, Andrea, Prochazka, Vit, Belada, David, Mocikova, Heidi, Steinerova, Katerina, Duras, Juraj, Karban, Josef, Hanackova, Veronika, Sykorova, Alice, Obr, Ales, Trneny, Marek

Volltext